Broadfin Capital’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $14.8M | Sell |
533,301
-597,800
| -53% | -$16.5M | 1.98% | 12 |
|
|
2019
Q3 | $20.6M | Sell |
1,131,101
-428,198
| -27% | -$7.79M | 3.81% | 3 |
|
|
2019
Q2 | $38.2M | Sell |
1,559,299
-2,769,004
| -64% | -$67.9M | 8.32% | 1 |
|
|
2019
Q1 | $41.2M | Sell |
4,328,303
-1,622,850
| -27% | -$15.4M | 8.5% | 1 |
|
|
2018
Q4 | $52.7M | Buy |
5,951,153
+1,056,792
| +22% | +$9.35M | 6.93% | 1 |
|
|
2018
Q3 | $55.1M | Buy |
4,894,361
+747,756
| +18% | +$8.41M | 8.1% | 1 |
|
|
2018
Q2 | $53.1M | Buy |
4,146,605
+3,233,618
| +354% | +$41.4M | 8.36% | 1 |
|
|
2018
Q1 | $15.4M | Sell |
912,987
-1,427,624
| -61% | -$24.1M | 2.4% | 17 |
|
|
2017
Q4 | $18.7M | Sell |
2,340,611
-147,011
| -6% | -$1.18M | 3.06% | 15 |
|
|
2017
Q3 | $19.3M | Buy |
2,487,622
+211,263
| +9% | +$1.64M | 2.85% | 13 |
|
|
2017
Q2 | $16.7M | Sell |
2,276,359
-232,700
| -9% | -$1.71M | 2.03% | 14 |
|
|
2017
Q1 | $18.7M | Sell |
2,509,059
-129,200
| -5% | -$963K | 2.26% | 14 |
|
|
2016
Q4 | $18.3M | Hold |
2,638,259
| – | – | 2.04% | 14 |
|
|
2016
Q3 | $21.7M | Sell |
2,638,259
-532,500
| -17% | -$4.38M | 1.95% | 12 |
|
|
2016
Q2 | $25.7M | Buy |
3,170,759
+1,065,240
| +51% | +$8.63M | 2.5% | 9 |
|
|
2016
Q1 | $10.7M | Hold |
2,105,519
| – | – | 1.03% | 23 |
|
|
2015
Q4 | $16.3M | Hold |
2,105,519
| – | – | 1% | 23 |
|
|
2015
Q3 | $12.1M | Buy |
2,105,519
+293,100
| +16% | +$1.69M | 0.67% | 33 |
|
|
2015
Q2 | $16.6M | Buy |
1,812,419
+750,000
| +71% | +$6.88M | 0.89% | 29 |
|
|
2015
Q1 | $12.9M | Buy |
+1,062,419
| New | +$12.9M | 1% | 23 |
|